Viscoelastic Properties of Hyaluronan in Physiological Conditions

Overview

Journal F1000Res

Specialties Biomedical Engineering
Science

Date 2015 Nov 24

PMID 26594344

Citations 108

Authors

Mary K Cowman

Tannin A Schmidt

Preeti Raghavan

Antonio Stecco

Affiliations

Soon will be listed here.

Abstract

Hyaluronan (HA) is a high molecular weight glycosaminoglycan of the extracellular matrix (ECM), which is particularly abundant in soft connective tissues. Solutions of HA can be highly viscous with non-Newtonian flow properties. These properties affect the movement of HA-containing fluid layers within and underlying the deep fascia. Changes in the concentration, molecular weight, or even covalent modification of HA in inflammatory conditions, as well as changes in binding interactions with other macromolecules, can have dramatic effects on the sliding movement of fascia. The high molecular weight and the semi-flexible chain of HA are key factors leading to the high viscosity of dilute solutions, and real HA solutions show additional nonideality and greatly increased viscosity due to mutual macromolecular crowding. The shear rate dependence of the viscosity, and the viscoelasticity of HA solutions, depend on the relaxation time of the molecule, which in turn depends on the HA concentration and molecular weight. Temperature can also have an effect on these properties. High viscosity can additionally affect the lubricating function of HA solutions. Immobility can increase the concentration of HA, increase the viscosity, and reduce lubrication and gliding of the layers of connective tissue and muscle. Over time, these changes can alter both muscle structure and function. Inflammation can further increase the viscosity of HA-containing fluids if the HA is modified via covalent attachment of heavy chains derived from Inter-α-Inhibitor. Hyaluronidase hydrolyzes HA, thus reducing its molecular weight, lowering the viscosity of the extracellular matrix fluid and making outflow easier. It can also disrupt any aggregates or gel-like structures that result from HA being modified. Hyaluronidase is used medically primarily as a dispersion agent, but may also be useful in conditions where altered viscosity of the fascia is desired, such as in the treatment of muscle stiffness.

Citing Articles

G-protein-coupled estrogen receptor 30 regulation of signaling downstream of protein kinase Cε mediates sex dimorphism in hyaluronan-induced antihyperalgesia.

Bonet I, Araldi D, Khomula E, Bogen O, Green P, Levine J Pain. 2025; 166(3):539-556.

PMID: 39787533 PMC: 11810595. DOI: 10.1097/j.pain.0000000000003419.

Versican controlled by Lmx1b regulates hyaluronate density and hydration for semicircular canal morphogenesis.

Mori Y, Smith S, Wang J, Eliora N, Heikes K, Munjal A Development. 2024; 152(1).

PMID: 39651757 PMC: 11829767. DOI: 10.1242/dev.203003.

Relations between daily stressful events, exertion, heart rate variability, and thoracolumbar fascia deformability: a case report.

Brandl A, Engel R, Egner C, Schleip R, Schubert C J Med Case Rep. 2024; 18(1):589.

PMID: 39623401 PMC: 11610301. DOI: 10.1186/s13256-024-04935-z.

Distribution and Incorporation of Extracellular Vesicles into Chondrocytes and Synoviocytes.

Ohtsuki T, Sato I, Takashita R, Kodama S, Ikemura K, Opoku G Int J Mol Sci. 2024; 25(22).

PMID: 39596012 PMC: 11593503. DOI: 10.3390/ijms252211942.

Ultrasound Imaging Comparison of Crural Fascia Thickness and Muscle Stiffness in Stroke Patients with Spasticity.

Choi J, Do Y, Lee H Diagnostics (Basel). 2024; 14(22).

PMID: 39594272 PMC: 11592608. DOI: 10.3390/diagnostics14222606.

References

Cowman M, Matsuoka S . Experimental approaches to hyaluronan structure. Carbohydr Res. 2005; 340(5):791-809. DOI: 10.1016/j.carres.2005.01.022. View

Tammi M, Day A, Turley E . Hyaluronan and homeostasis: a balancing act. J Biol Chem. 2001; 277(7):4581-4. DOI: 10.1074/jbc.R100037200. View

de la Motte C, Hascall V, Drazba J, Bandyopadhyay S, Strong S . Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol. 2003; 163(1):121-33. PMC: 1868154. DOI: 10.1016/s0002-9440(10)63636-x. View

Loewenstein W, Skalak R . Mechanical transmission in a Pacinian corpuscle. An analysis and a theory. J Physiol. 1966; 182(2):346-78. PMC: 1357475. DOI: 10.1113/jphysiol.1966.sp007827. View

Stecco C, Pavan P, Porzionato A, Macchi V, Lancerotto L, Carniel E . Mechanics of crural fascia: from anatomy to constitutive modelling. Surg Radiol Anat. 2009; 31(7):523-9. DOI: 10.1007/s00276-009-0474-2. View

Laurent T, Laurent U, Fraser J . The structure and function of hyaluronan: An overview. Immunol Cell Biol. 1996; 74(2):A1-7. DOI: 10.1038/icb.1996.32. View

Sanggaard K, Sonne-Schmidt C, Krogager T, Kristensen T, Wisniewski H, Thogersen I . TSG-6 transfers proteins between glycosaminoglycans via a Ser28-mediated covalent catalytic mechanism. J Biol Chem. 2008; 283(49):33919-26. PMC: 2662217. DOI: 10.1074/jbc.M804240200. View

Bell J, Holmes M . Model of the dynamics of receptor potential in a mechanoreceptor. Math Biosci. 1992; 110(2):139-74. DOI: 10.1016/0025-5564(92)90034-t. View

Milner C, Higman V, Day A . TSG-6: a pluripotent inflammatory mediator?. Biochem Soc Trans. 2006; 34(Pt 3):446-50. DOI: 10.1042/BST0340446. View

10.

Huang L, Yoneda M, Kimata K . A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J Biol Chem. 1993; 268(35):26725-30. View

11.

Ludwig T, Cowman M, Jay G, Schmidt T . Effects of concentration and structure on proteoglycan 4 rheology and interaction with hyaluronan. Biorheology. 2015; 51(6):409-22. DOI: 10.3233/BIR-14037. View

12.

PIGMAN W, Hawkins W, GRAMLING E, Rizvi S, HOLLEY H . Factors affecting the viscosity of hyaluronic acid and synovial fluid. Arch Biochem Biophys. 1960; 89:184-93. DOI: 10.1016/0003-9861(60)90041-2. View

13.

Huang Z, Zhao C, Chen Y, Cowell J, Wei G, Kultti A . Recombinant human hyaluronidase PH20 does not stimulate an acute inflammatory response and inhibits lipopolysaccharide-induced neutrophil recruitment in the air pouch model of inflammation. J Immunol. 2014; 192(11):5285-95. DOI: 10.4049/jimmunol.1303060. View

14.

Torihashi S, Ho M, Kawakubo Y, Komatsu K, Nagai M, Hirayama Y . Acute and temporal expression of tumor necrosis factor (TNF)-α-stimulated gene 6 product, TSG6, in mesenchymal stem cells creates microenvironments required for their successful transplantation into muscle tissue. J Biol Chem. 2015; 290(37):22771-81. PMC: 4566248. DOI: 10.1074/jbc.M114.629774. View

15.

Gribbon P, Heng B, Hardingham T . The molecular basis of the solution properties of hyaluronan investigated by confocal fluorescence recovery after photobleaching. Biophys J. 1999; 77(4):2210-6. PMC: 1300501. DOI: 10.1016/S0006-3495(99)77061-X. View

16.

Majors A, Austin R, de la Motte C, Pyeritz R, Hascall V, Kessler S . Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J Biol Chem. 2003; 278(47):47223-31. DOI: 10.1074/jbc.M304871200. View

17.

Kwiecinski J, Dorosz S, Ludwig T, Abubacker S, Cowman M, Schmidt T . The effect of molecular weight on hyaluronan's cartilage boundary lubricating ability--alone and in combination with proteoglycan 4. Osteoarthritis Cartilage. 2011; 19(11):1356-62. DOI: 10.1016/j.joca.2011.07.019. View

18.

Lieber R, Steinman S, Barash I, Chambers H . Structural and functional changes in spastic skeletal muscle. Muscle Nerve. 2004; 29(5):615-27. DOI: 10.1002/mus.20059. View

19.

Volpi N, Schiller J, Stern R, Soltes L . Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem. 2009; 16(14):1718-45. DOI: 10.2174/092986709788186138. View

20.

Stecco C, Porzionato A, Lancerotto L, Stecco A, Macchi V, Day J . Histological study of the deep fasciae of the limbs. J Bodyw Mov Ther. 2008; 12(3):225-30. DOI: 10.1016/j.jbmt.2008.04.041. View